KILITCH DRUGS (INDIA) LTD. - 524500 - Shareholding for the Period Ended September 30, 2020
Kilitch Drugs India Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2020. For more details, kindly Click here19-10-2020
19-10-2020
KILITCH DRUGS (INDIA) LTD. - 524500 - Certificate Under Regulation 40(9) Of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015
With reference to Regulation 40(9) of Securities Exchange Board of India (Listing Obligations & Disclosure Requirements) Regulations, 2015, please find attached herewith the certificate dated 12th October, 2020 received from M/s. Deep Shukla & Associates, Practicing Company Secretaries for the half year ended 30th September 2020. Kindly take the same into your records.16-10-2020
KILITCH DRUGS (INDIA) LTD. - 524500 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on October 16, 2020 for Bhavin Mehta16-10-2020
KILITCH DRUGS (INDIA) LTD. - 524500 - Statement Of Investor Complaints For The Quarter Ended September 2020
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Sunita GohilDesignation :- Company Secretary and Compliance Officer12-10-2020
KILITCH DRUGS (INDIA) LTD. - 524500 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
We are enclosing herewith certificate issued by the Registrar & Share Transfer Agent M/s. Link Intime India Private Limited confirming the compliance of Regulation 74 (5) of SEBI (Depositories and Participants) Regulations, 2018. This is for your information and records.12-10-2020
KILITCH DRUGS (INDIA) LTD. - 524500 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
We wish to inform you that pursuant to Regulation 30 read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform that the Board of Directors of the company have considered & approved the Allotment of 15471 Equity shares of Rs. 10 each on October 6, 2020 pursuant to exercise of option granted to employees of the Company under ESOS Scheme. The above is for information and dissemination to the public at large.06-10-2020
KILITCH DRUGS (INDIA) LTD. - 524500 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
In continuation of our letter dated 1st October, 2020, we would like to inform you that due to typo error in Voting results, we have mentioned ' Oridinary Resolution' instead of 'Special Resolution', and hence we are re-submitting the Scrutinizer report as well as Voting Results to your esteemed exchange. Mr. Deep Shukla, proprietor of M/s. Deep Shukla & Associates, Company Secretaries was appointed as the Scrutinizer to scrutinize the voting conducted through remote e-voting for the AGM The Scrutinizer''s report dated 30th September, 2020, is attached as "Annexure-I". In terms if the provisions of Regulation 44 (3) of the SEBI (Listing Obligations & Disclosure Requirements), Regulations, 2015, the details of the results held through remote E-voting is attached herewith as "Annexure- II" You are requested to kindly take the revised one in your record.05-10-2020
KILITCH DRUGS (INDIA) LTD. - 524500 - Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Kilitch Drugs India Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here02-10-2020
KILITCH DRUGS (INDIA) LTD. - 524500 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
The Company''s 28th Annual General Meeting (AGM) was held on Wednesday, 30th September, 2020 at 9:00 A.M. through Video Conferencing (VC)/ Other Audio Visual Means (OAVM) In terms of the provisions of the Companies Act, 2013 and Rules made thereunder and as per the provisions of SEBI (Listing Obligations & Disclosure Requirements), Regulations, 2015, the Company had provided remote E-voting facility to its members. Mr. Deep Shukla, proprietor of M/s. Deep Shukla & Associates, Company Secretaries was appointed as the Scrutinizer to scrutinize the voting conducted through remote e-voting for the AGM The Scrutinizer''s report dated 30th September, 2020, is attached as "Annexure-I". In terms if the provisions of Regulation 44 (3) of the SEBI (Listing Obligations & Disclosure Requirements), Regulations, 2015, the details of the results held through remote E-voting is attached herewith as "Annexure- II" You are requested to take the same in your records.01-10-2020
KILITCH DRUGS (INDIA) LTD. - 524500 - Closure of Trading Window
With reference to the above subject, this is to inform you that pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended from time to time read with NSE Circular Reference no. NSE/CML/2019/11 and BSE Circular Reference no. LIST/COMP/01/2019-20, both dated April 02, 2019 Trading Window for dealing in Securities of the Company will remain closed for all Directors, Officers, Designated Persons of the Company and their immediate relatives with effect from Thursday, October 01, 2020 till 48 hours after the declaration of Financial Results of the Company for the quarter & half year ended September 30, 2020. The date of meeting of Board of Directors to approve the Financial Results of the Company for the quarter & half year ended September 30, 2020 will be informed in due course.30-09-2020